Loading clinical trials...
Loading clinical trials...
A Single Arm, Open-Label, Phase 1b Trial of Epcoritamab in Pediatric Patients With Relapsed/Refractory Aggressive Mature B-cell Neoplasms
Conditions
Interventions
Epcoritamab
Locations
41
United States
Lucile Packard Children's Hospital /ID# 240854
Palo Alto, California, United States
Nicklaus Children's Hospital /ID# 241174
Miami, Florida, United States
New York Medical College /ID# 239208
Valhalla, New York, United States
Levine Children's Hospital /ID# 242765
Charlotte, North Carolina, United States
Cincinnati Childrens Hospital Medical Center /ID# 239823
Cincinnati, Ohio, United States
Children's Hospital of Philadelphia - Main /ID# 239294
Philadelphia, Pennsylvania, United States
Start Date
October 4, 2022
Primary Completion Date
November 1, 2028
Completion Date
November 1, 2028
Last Updated
April 8, 2025
NCT06090539
NCT07260812
NCT07523555
NCT06189391
NCT05006716
NCT06026319
Lead Sponsor
Genmab
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions